2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC1043
Submitter : Dr. Sue Klein Date & Time: 10/27/2005 10:10:30
Organization : Feminist Majority Foundation
Category : Consumer Group
Issue Areas/Comments
GENERAL
GENERAL
The FDA is loosing credibility with many who had long valued its role in using good scientific evidence to advance and protect our health. It should immediately approve Plan B as recommended by its own panels of advisors and expert civil service staff.

Thank You, Dr. Sue Klein